Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

10.43 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/01/18H.C. WainwrightAssumesBuy23.0
1/29/18Ladenburg ThalmannInitiates Coverage OnBuy25.5
1/26/18Seaport GlobalInitiates Coverage OnBuy16.0
10/02/17Cantor FitzgeraldUpgradesOverweight
9/29/17Canaccord GenuityMaintainsBuy15.0
9/29/17PiperJaffrayUpgradesOverweight
8/21/17Canaccord GenuityMaintainsBuy9.0
8/15/17OppenheimerDowngradesMarket Perform
8/15/17JefferiesDowngradesHold
8/08/17H.C. WainwrightDowngradesNeutral7.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter